Seqker

Founded: 2021 • Age: 5 yrs
Advances personalized cancer therapies through genomic profiling and vaccine development.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 4 Services tracked
Competitors 10 Brand Intelligence

About Seqker

Seqker is a company founded in 2021. It operates as a B2B and Service-based. Seqker offers products and services including Neoantigen Cancer Vaccine, Genomic Profiling, Preclinical Target Discovery, and Intelligent Platform. Seqker operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.

  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Seqker Biosciences, Inc.
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Seqker

Seqker offers a comprehensive portfolio of products and services, including Neoantigen Cancer Vaccine, Genomic Profiling, Preclinical Target Discovery, and Intelligent Platform.

Product name locked
Category locked
Primary

Personalized vaccine based on tumor neoantigens for cancer treatment.

Product name locked
Category locked
Locked

Analyzes tumor and normal samples for actionable drug targets.

Product name locked
Category locked
Locked

Identifies novel neoantigens for cancer indications via analysis.

Product name locked
Category locked
Locked

Modular tool for genomics examination and neoantigen prediction.

Funding Insights of Seqker

Premium access

Detailed funding history for Seqker

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Seqker

Investments
Premium access

Investment portfolio details for Seqker

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Seqker

Premium access

Detailed financials for Seqker

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Seqker Comparisons

Seqker Primary company
Description
Advances personalized cancer therapies through genomic profi...
Location
-
Founded Year
2021
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Seqker

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Seqker

Seqker operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
mRNA-based therapeutics for diseases including cancer and infections are developed.
Locked Locked Locked
Novel biopharmaceutical medicines are developed for unmet medical needs.
Locked Locked Locked
Targeted and immune-oncology drugs for cancer treatment are developed.
Locked Locked Locked
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
Locked Locked Locked
Small molecules are developed for cancer and skin disease treatments.
Locked Locked Locked
Cancer therapies are developed using selective pathway inhibitors.
Premium access

Detailed competitors of Seqker

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Seqker

Premium access

Complete news archive for Seqker

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seqker

Seqker was founded in 2021.

Seqker Biosciences is a platform-driven company focused on advancing personalized cancer treatments and diagnostics. It uses modular technology to analyze patients genomics for accurate neoantigen predictions and drug target identification. The company offers services like neoantigen cancer vaccine treatments, comprehensive genomic profiling, and preclinical target discovery through collaborations. Based on the provided text, it operates in a network of hospitals and partners with academia for innovation.

Seqker's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.

Seqker offers Neoantigen Cancer Vaccine, Genomic Profiling, Preclinical Target Discovery, and Intelligent Platform.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available